42908-33-8,
N-[(4-Methylphenyl)sulfonyl]-beta-alanine,
3-(Toluene-4-sulfonylamino)-propionic acid,
3-(4-Methylphenylsulfonamido)propanoic acid,
PPDKUGSOVUQARL-UHFFFAOYSA-N,
3-(4-methylbenzenesulfonamido)propanoic acid,
3-{[(4-methylphenyl)sulfonyl]amino}propanoic acid,
SR-01000510752,
n-tosyl-beta-alanine,
NSC105599,
CBKinase1_000024,
CBKinase1_012424,
AC1L6GU9,
AC1Q2LP3,
AC1Q2LP4,
AC1Q6U5R,
3-[(4-methylphenyl)sulfonylamino]propanoic acid,
Oprea1_061052,
Oprea1_750438,
CBDivE_002993,
CBDivE_007925,
MLS000067640,
SCHEMBL4541169,
CHEMBL1412589,
CTK4I6775,
ZINC51263,
DTXSID70295805,
HMS2170B07,
ALBB-012910,
3228AE,
BBL002325,
MFCD00453693,
SBB042105,
STK288067,
AKOS000264186,
CS-W000084,
MCULE-4813317443,
NSC-105599,
b-Alanine,N-[(4-methylphenyl)sulfonyl]-,
BAS 00315020,
SMR000125019,
AB0157746,
Propionic acid, 3-(4-tolylsulfonylamido)-,
BB 0219389,
FT-0683648,
R3094,
ST45244522,
beta-alanine, N-[(4-methylphenyl)sulfonyl]-,
EN300-04285,
N-[(4-Methylphenyl)sulfonyl]-beta-alanine #,
3-[(4-methylbenzene)sulfonamido]propanoic acid,
AE-641/01680021,
SR-01000510752-2,
BRD-K37615544-001-01-8,
I14-27671,
C10H13NO4S,
AR-1L8624,
CID266802,
|A-alanine, n-[(4-methylphenyl)sulfonyl]-,
2-methyl-5-[5-(morpholin-4-ylcarbonyl)-1,2,4-oxadiazol-3-yl]-N-[4-(trifluoromethyl)phenyl]benzenesulfonamide,
4348-76-9,